Nuformix Secures Key Patents and Outlines Future Plans for NXP002 and NXP004 Nuformix excited as it moves focus to NXP002 and NXP004 programmes Nufomix Investor Webinar 13 June 2023 Nuformix NXP002 meets best case scenario objectives (interview 28 March 2023) Nuformix Investor Webinar 9 November 2022 Nuformix lead programme introduced to major respiratory players
